Skip to main content
. 2017 Sep 28;8(65):108676–108691. doi: 10.18632/oncotarget.21358

Figure 2. CLSM and FCM images of the PLGA-PFOB NPs modified with cRGD.

Figure 2

cRGD-PLGA-PFOB NPs modified with cRGD were prepared in the presence of Nile Red to stain for PLGA-PFOB NPs, and a FITC label was used for cRGD peptides. (A) Nile Red. (B) FITC. (C) Merge. (D) FCM image of PLGA-PFOB NPs. (E) FCM image of PLGA-PFOB NPs modified with FITC-labeled cRGD peptide.